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We read with great interest the important results of IBCSG 43-
09 HOHO, a European multicentre cohort study investigating
fertility, psychosocial and quality of life concerns in young (40
years) breast cancer patients [1]. Despite more than half of young
womenwith newly diagnosed breast cancer were concerned about
risk of chemotherapy-induced infertility and wished to have future
children, only 9% (28/297) of them underwent embryo, oocyte or
ovarian tissue cryopreservation before starting systemic anticancer
therapies [1].
Similar results were shown in the US HOHO study and our Ital-
ian PREFER studywith an acceptance rate for cryopreservation stra-
tegies of approximately 10% [2,3].
In a recent survey among breast cancer specialists, lack of
collaboration between oncology and fertility units was considered
one of the important factors preventing access to cryopreservation
strategies; approximately 60% of respondents supported the need
to have a specialized fertility unit within the same institution of
the oncology centre [4]. Nevertheless, considering the small num-
ber of patients requiring access to cryopreservation strategies,
implementing an hub and spoke model (with several oncology
centre referring interested patients at a major and more experi-
enced fertility unit) may help to overcome these obstacles also
improving success rates and cost-effectiveness of these procedures.
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